Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Short-term Investments: 2010-2020

Historic Short-term Investments for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2020 value amounting to $613.9 million.

  • Neurocrine Biosciences' Short-term Investments fell 12.44% to $454.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $454.8 million, marking a year-over-year decrease of 12.44%. This contributed to the annual value of $613.9 million for FY2020, which is 9.98% up from last year.
  • As of FY2020, Neurocrine Biosciences' Short-term Investments stood at $613.9 million, which was up 9.98% from $558.2 million recorded in FY2019.
  • In the past 5 years, Neurocrine Biosciences' Short-term Investments registered a high of $613.9 million during FY2020, and its lowest value of $224.1 million during FY2016.
  • In the last 3 years, Neurocrine Biosciences' Short-term Investments had a median value of $558.2 million in 2019 and averaged $560.4 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Short-term Investments fell by 26.53% in 2016, and later soared by 94.93% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Short-term Investments (Yearly) stood at $224.1 million in 2016, then grew by 16.57% to $261.2 million in 2017, then surged by 94.93% to $509.2 million in 2018, then rose by 9.62% to $558.2 million in 2019, then rose by 9.98% to $613.9 million in 2020.